16/03/2015

ESTEVE RECEIVES TWO AWARDS TO THE 2014 BEST PHARMACY INITIATIVES OF CORREO FARMACÉUTICO

The annual prize awarded by Correo Farmacéutico goes to a new omeprazole formulation in the category of Research, Pharmacology and Products, and to the MAPAfarma project in the category of Pharmaceutical Care and Health Education.

The first award goes to an optimized formulation of omeprazole, a stomach protector developed by Esteve's generics subsidiary PENSA at its innovation and pharmaceutical production center in Martorelles (Barcelona). This landmark is the fruit of constant innovation and has positioned ESTEVE as a reference company in the field of stomach protection technology, know-how and innovation.

The second award goes to ESTEVE's collaboration with the College of Pharmacists of Andalusia to implement the MAPAfarma project, aimed at providing pharmacies with a new Ambulatory Blood Pressure Monitoring service where readings are obtained every 20 or 30 minutes for periods of 24 or 48 hours to help better manage hypertension -a disease affecting 14 Million Spaniards.

The Best Pharmacy Initiatives Awards of Correo Farmacéutico acknowledge the daily work of people, institutions or companies who have helped improve the world of pharmacy, pharmaceutical care and health. These awards include 6 categories: Pharmaceutical Policy and Legal Initiatives; Profession and Deontology; Pharmaceutical Care and Health Education; Research, Pharmacology and Products, Management; Training, Solidarity Projects and Patronage.



You can follow ESTEVE on Twitter at this link: twitter.com/esteve_news.

Last news

  • ESTEVE APPOINTS JORDI MUNTAÑOLA AS CHIEF COMMERCIAL OFFICER FOR EUROPE

    Jordi Muntañola will take on the leadership of all the pharmaceutical activities in Spain and Europe

    read more
  • POMPEU FABRA UNIVERSITY AND ESTEVE ARE TO INVESTIGATE NEW TARGETS FOR TREATING NEUROPATHIC PAIN

    The RIBOPAIN project aims to identify new therapeutic solutions for pain and to develop more effective drugs

    read more
  • ESTEVE ANNOUNCES A RESTRUCTURING OF ITS PHARMACEUTICAL ACTIVITY

    Esteve Pharmaceuticals submits a reduction in force (RIF) which will affect 103 jobs in Spain

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.